Inhibitors of cannabinoid receptors and glucose metabolism
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Nutrition and Dietetics,Medicine (miscellaneous)
Reference57 articles.
1. The endocannabinoid system: a general view and latest additions
2. Cannabinoid physiology and pharmacology: 30 years of progress
3. The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
4. The endocannabinoid system and its therapeutic exploitation
5. Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis;International Journal of Molecular Sciences;2019-05-22
2. Acute and subacute antidiabetic studies of ENP-9, a new 1,5-diarylpyrazole derivative;Journal of Pharmacy and Pharmacology;2018-05-17
3. Contribution of Phospholipid, Sphingolipids, and Cholesterol-Derived Lipid Mediators in the Pathogenesis of Metabolic Syndrome and Neurological Disorders;Metabolic Syndrome and Neurological Disorders;2013-10-11
4. CB1 antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogs;American Journal of Physiology-Endocrinology and Metabolism;2012-05-15
5. Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk;Expert Opinion on Drug Discovery;2011-09-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3